Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma
NCT07636252
·
clinicaltrials.gov ↗
RECRUITING
Status
400
Enrollment
OTHER_GOV
Sponsor class
Conditions
Lung Adenocarcinoma
Malignant Pleural Effusions (Mpe)
Interventions
OTHER:
Non-Interventional Study
Sponsor
Sheba Medical Center